Corcept (CORT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues. CORT's Cushing's syndrome drug, Korlym, is driving revenues.
All products featured on Architectural Digest are independently selected by our editors. However, when you buy something through our retail links, we may earn an affiliate commission. The best ...
Learn more We're closing in on the biggest shopping holiday of the year, and all of the best Black Friday furniture deals are live. The verdict: The deals look good. In fact, we've spotted savings ...
The ongoing saga over the relocation of Henry Cort school in Fareham has cost taxpayers in Hampshire around £5,000. Hampshire County Council approved a formal consultation (October 25) for the ...